Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|February 15, 2022
Histamine H4 Receptor Agonism Induces Antitumor Effects in Human T-Cell LymphomaMariángeles Clauzure, Mónica A Táquez Delgado, Jude M Phillip, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2020
The eukaryotic translation initiation factor eIF4E elevates steady-state m7G capping of coding and noncoding transcriptsBiljana Culjkovic-Kraljacic, Lucy Skrabanek, Maria V Revuelta, et al.
Annals of Hematology|June 21, 2026
Phase I study of oral azacitidine plus salvage chemotherapy in relapsed/refractory diffuse large B-cell lymphomaBrian Hess, Nina D Wagner-Johnston, Lindsey Hendrickson, et al.
Molecular Cancer Therapeutics|July 6, 2022
Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell LymphomaFlorencia Cayrol, Maria V Revuelta, Mercedes Debernardi, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Cancer Discovery|February 5, 2021
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental SignaturesNikita Kotlov, Alexander Bagaev, Maria V Revuelta, et al.
Cancer Research|September 4, 2021
Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell LymphomasM Nieves Calvo-Vidal, Nahuel Zamponi, Jan Krumsiek, et al.
Blood|February 16, 2023
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCLJia Ruan, Alison Moskowitz, Neha Mehta-Shah, et al.
Cancer Research|October 6, 2023
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer CellsRossella Marullo, Sarah C Rutherford, Maria V Revuelta, et al.
Research Square|April 2, 2024
Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphomaValeria Cancila, Gaia Morello, Giorgio Bertolazzi, et al.
Pageof 2